Dying with dementia in Medicare Advantage, Accountable Care Organizations, or traditional Medicare
- 14 May 2021
- journal article
- research article
- Published by Wiley in Journal of the American Geriatrics Society
- Vol. 69 (10), 2802-2810
- https://doi.org/10.1111/jgs.17225
Abstract
Background/Objective Medicare Advantage (MA) and Accountable Care Organizations (ACOs) operate under incentives to reduce burdensome and costly care at the end of life. We compared end‐of‐life care for persons with dementia who are in MA, ACOs, or traditional Medicare (TM). Design, Setting, and Participants Retrospective study of decedents with dementia enrolled in MA, attributed to an ACO, or in TM. Decedents had a nursing home stay between 91 and 180 days prior to death, two or more functional impairments, and mild to severe cognitive impairment. Measurements Hospitalization, invasive mechanical ventilation (IMV) use, and in‐hospital death in the last 30 days of life reported in Medicare billing. Results Among 370,094 persons with dementia, 93,801 (25.4%) were in MA (mean age [SD], 86.9 [7.7], 67.6% female), 39,586 (10.7%) were ACO attributed (mean age [SD], 87.2 [7.6], 67.3% female), and 236,707 (63.9%) were in TM (mean age [SD], 87.0 [7.8], 67.6% female). The proportion hospitalized in the last 30 days of life was higher among TM enrollees (27.9%) and those ACO attributed (28.1%) than among MA enrollees (20.5%, p ≤ 0.001). After adjustment for socio‐demographics, cognitive and functional impairments, comorbidities, and Hospital Referral Region, adjusted odds of hospitalization in the 30 days prior to death was 0.72 (95% confidence interval [CI] 0.70–0.74) among MA enrollees and 1.05 (95% CI 1.02–1.09) among those attributed to ACOs relative to TM enrollees. Relative to TM, the adjusted odds of death in the hospital were 0.78 (95% CI 0.75–0.81) among MA enrollees and 1.02 (95% CI 0.96–1.08) for ACO participants. Dementia decedents in MA had a lower likelihood of IMV use (adjusted odds ratio 0.80, 95% CI 0.75–0.85) compared to TM. Conclusions Among decedents with dementia, MA enrollees but not decedents in ACOs experienced less costly and potentially burdensome care compared with those with TM. Policy changes are needed for ACOs.Funding Information
- National Institute on Aging (2P01AG027296‐11)
This publication has 34 references indexed in Scilit:
- The Minimum Data Set 3.0 Cognitive Function ScaleMedical Care, 2017
- National trends in hospital admissions for asthma exacerbations among pediatric and young adult population in Spain (2002–2010)Respiratory Medicine, 2014
- Health Insurance Status and the Care of Nursing Home Residents With Advanced DementiaJAMA Internal Medicine, 2013
- Service Use at the End-of-Life in Medicare Advantage Versus Traditional MedicareMedical Care, 2013
- End-of-Life Transitions among Nursing Home Residents with Cognitive IssuesThe New England Journal of Medicine, 2011
- The Clinical Course of Advanced DementiaThe New England Journal of Medicine, 2009
- Clinical and Organizational Factors Associated With Feeding Tube Use Among Nursing Home Residents With Advanced Cognitive ImpairmentJAMA, 2003
- Clinical and Organizational Factors Associated With Feeding Tube Use Among Nursing Home Residents With Advanced Cognitive ImpairmentJAMA, 2003
- Use of Feeding Tubes in Nursing Home Residents With Severe Cognitive ImpairmentJAMA, 2002
- Use of Feeding Tubes in Nursing Home Residents With Severe Cognitive ImpairmentJAMA, 2002